2006
DOI: 10.1016/j.transproceed.2006.06.082
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Apoptosis in Peripheral Blood Lymphocytes of Renal Transplant Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Cytokines and the molecules associated with cytolytic effector functions of T lymphocytes have long been studied as surrogates of AR and as possible candidates to the development of a non-invasive diagnostic tool [18][19][20][21][22][23]. Although with some good initial results, none of the proposed markers studied, until now, are being used routinely in the clinical practice or gained full acceptance.…”
Section: Discussionmentioning
confidence: 99%
“…Cytokines and the molecules associated with cytolytic effector functions of T lymphocytes have long been studied as surrogates of AR and as possible candidates to the development of a non-invasive diagnostic tool [18][19][20][21][22][23]. Although with some good initial results, none of the proposed markers studied, until now, are being used routinely in the clinical practice or gained full acceptance.…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have shown decreased expression of Fas (CD95) on peripheral blood lymphocytes but increased Fas (CD95) expression on tumour-infiltrating lymphocytes in patients with renal cell carcinoma in comparison with healthy volunteers [31]. However, other studies suggest that peripheral blood mononuclear cells of kidney transplant recipients are more susceptible to activation-induced cell death and that the Fas-FasL pathways is involved in this process [32]. Similar results were obtained in patients with non-small cell lung cancer.…”
Section: Discussionmentioning
confidence: 99%